Hesperion Acquires TouchStone Research Inc.
"With ten years of successful North American CRO operations, many more years of clinical development expertise, and a proven track record with pharmaceutical companies and CROs, B.G. White, PhD, President and CEO of TouchStone Research Inc, together with the senior managers of TouchStone Research are bringing their extensive US experience to Hesperion. TouchStone Research Inc. will ideally complement our existing North American operations and the numerous synergies we have identified will provide substantial added value to our clients and partners" said Vincent Charlon, CEO of Hesperion.
The combined company will operate under the Hesperion name and with the same set of global quality processes and systems. The integration of the complementary operations of both companies will be seamless to any and all clients of either TouchStone Research or Hesperion. In his new functions, Dr White will assume the new responsibilities of Executive Vice-president and Chief Scientific Officer for Hesperion North America.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.